Publications by authors named "Aleesha Jantzen"
Recent literature demonstrated a 24-hour reduction in vancomycin duration of therapy (DOT) for skin and soft tissue infections (SSTIs) with a negative methicillin-resistant staphylococcus aureus (MRSA) nasal screening versus a positive nasal screening. Objective of this study was to investigate vancomycin DOT in patients with SSTIs who received MRSA nasal polymerase chain reaction (PCR) screening versus those who did not receive MRSA nasal PCR screening. A retrospective, multi-center, cohort study was completed in admitted adult patients on vancomycin for SSTI from 01/01/2020 to 09/30/2022.
View Article and Find Full Text PDFArticle Synopsis
- The study utilizes pharmacy claims data from a commercial health plan to pinpoint opportunities for screening and intervention in opioid use disorder (OUD) through targeted messaging to prescribers.
- Participants were members aged 18 and older who were on high doses of opioids, with exclusions for those on specific chemotherapy drugs, and the intervention involved sending prescribers resources for OUD management.
- Of the 745 members identified, 20 were assessed for OUD risk, leading to provider communications; 55% of patients had some documented intervention after their providers received the recommendations, indicating that targeted messaging can enhance recognition and intervention for OUD.